Keyphrases
Myristoylated Alanine-rich C Kinase Substrate
66%
Renal Cell Carcinoma
43%
Phosphorylation
36%
A1 Receptor
33%
Unresponsiveness
33%
Computational Modeling
33%
Insulin-like
33%
Paclitaxel
33%
Metabolic Homeostasis
33%
Kidney Cancer
33%
Tankyrase
33%
Methylthioadenosine Phosphorylase
33%
Therapeutic Target
33%
Breast Cancer
33%
AMPK Signaling
33%
Growth Factors
33%
Drug Bioavailability
33%
Tumorigenesis
33%
Liver Kinase B1 (LKB1)
33%
Oral Bioavailability
33%
Artificial Intelligence
22%
Intelligence Learning
17%
Renal Carcinoma Cells
15%
LKB1-AMPK Pathway
12%
Metabolic Disease
11%
Drug Development
11%
In Silico Prediction
11%
Modeling Techniques
11%
State-of-the-art Technology
11%
Therapeutic Efficacy
11%
Computational Modeling Methods
11%
Physiologically-based Pharmacokinetic Model
11%
Stopping Strategies
11%
Technical Improvement
11%
Machine Learning Neural Network
11%
Machine Learning
11%
Reliability Prediction
11%
Prediction Accuracy
11%
Drug Discovery
11%
Latest Technology
11%
Hypoxia-inducible Factor
10%
Tumor Grade
8%
RNF146
8%
AMPK Activation
8%
Tankyrase Inhibitor
8%
Regorafenib
6%
Kidney Cancer Cell
6%
Multikinase Inhibitor
6%
Cell Migration
6%
Linsitinib
6%
Biochemistry, Genetics and Molecular Biology
Myristoylated Alanine Rich C Kinase Substrate
100%
Carcinogenesis
41%
Ubiquitination
38%
Ubiquitin Ligase
38%
Upregulation
36%
Artificial Intelligence
33%
AMP-activated Protein Kinase
33%
AMPK Signaling
33%
Homeostasis
33%
Drug Response
33%
N-Terminus
33%
Insulin-Like Growth Factor 1 Receptor
33%
Deubiquitinating Enzyme
33%
Tumor Suppressor Protein
33%
Phosphorylase
33%
Signaling Protein
33%
Gene Signature
33%
Cancer Cell
30%
Cell Membrane
17%
Pharmacokinetic
16%
calcium activated,phospholipid dependent protein kinase
11%
Overall Survival
11%
Drug Therapy
11%
Chemogenomics
11%
Hypoxia-Inducible Factors
10%
Survival Time
8%
Metabolic Disorder
7%
Mammalian Target of Rapamycin
6%
Regorafenib
6%
Cell Migration
6%
Tyrosine Phosphorylation
6%
Angiogenesis
5%
Medicine and Dentistry
MARCKS Protein
100%
In Vitro
36%
Breast Cancer
33%
Upregulation
33%
Signaling Protein
33%
Kidney Cancer
33%
Cancer
33%
COVID-19
33%
Tamsulosin
33%
Paclitaxel
33%
Clear Cell Renal Cell Carcinoma
13%
Cell Membrane
12%
Neoplasm
12%
calcium activated,phospholipid dependent protein kinase
11%
Hypoxia Inducible Factor
10%
Cytosol
8%
Carcinogenesis
8%
Cancer Cell
8%
Regorafenib
6%
Mammalian Target of Rapamycin
6%
Metastatic Carcinoma
6%
Angiogenesis
5%
